Impact of BacT/Alert® VIRTUO®, BioFire® Blood Culture Identification 2-BCID2 and REVEAL® (bioMérieux) on the Optimization of Antibiotic Therapy for Gram-negative Bacteremia in the ICU

Inclusion Criteria

• •The patient must be a member or beneficiary of a health insurance plan
• •Patient admitted to the ICU with at least one positive blood culture for Gram-negative bacteremia
• •For the 'after' section of the study only:
• •Patient must have given their free and informed consent or included by emergency procedure
• •Patient signed the consent form or included by emergency procedure